Beckman Coulter UK Ltd
Little Chalfonts
COMPANY INFORMATION
Beckman Coulter Diagnostics is a global leader in advanced diagnostics, helping laboratories transform insight into impact through science, technology, and collaboration. For more than 90 years, the company has challenged convention to elevate the role of the diagnostic laboratory, accelerating ideas from discovery to real world clinical outcomes. Guided by its mission to Relentlessly Reimagine Healthcare, One Diagnosis at a Time, Beckman Coulter Diagnostics delivers trusted solutions for complex clinical testing across hospitals and reference laboratories worldwide, supported by an extensive clinical menu, scalable automation, actionable informatics, and lab performance optimisation services. Part of Danaher, a global science and technology innovator, Beckman Coulter Diagnostics benefits from connected science at global scale to help solve some of healthcare's most complex challenges—together. With its headquarters in Brea, California, the company has a workforce of over 11,000 employees around the world.
LATEST STORIES
PRODUCTS AND SERVICES
Latest Issues
DiaSorin is an Italian multinational Group and a global leader in the market for in vitro diagnostics. DiaSorin is listed on the MTA (automated stock market) in the FTSE Italia Mid Cap Index, organized and managed by Borsa Italiana S.p.A
For over 40 years the Group has been developing, producing and commercializing diagnostic tests for a wide...
UKHSA Conference 2026
Manchester Central, Manchester, M2 3GX
22-23 September, 2026
Cardiac Marker Dialogues
Technology and Innovation Centre, University of Strathclyde, 99 George Street, Glasgow, G1 1RD
24-25 September, 2026
46th European Congress of Cytology
Hilton Antwerp Old Town, Antwerp
4-7 October, 2026
UK NEQAS webinar: Introduction to Cellular Components, Tissue Morphology and Tissue Recognition
Online
6-7 October, 2026
Introduction to Cellular Components, Tissue Morphology and Tissue Recognition Master Class
The Haylofts, St Thomas Street, Haymarket, Newcastle, NE1 4LE, UK
8 October, 2026